mGlu5-dependent modulation of anxiety during early withdrawal from binge-drinking in adult and adolescent male mice

Drug Alcohol Depend. 2018 Mar 1:184:1-11. doi: 10.1016/j.drugalcdep.2017.10.031. Epub 2018 Jan 5.

Abstract

Binge alcohol-drinking elicits symptoms of negative affect such as anxiety upon cessation, which is a source of negative reinforcement for perpetuating this pattern of alcohol abuse. Binge-induced anxiety during early (24 h) withdrawal is associated with increased expression of metabotropic glutamate receptor 5 (mGlu5) within the nucleus accumbens shell (AcbSh) of adult male mice, but was unchanged in anxiety-resilient adolescents. Herein, we determined the role of mGlu5 signaling in withdrawal-induced anxiety via pharmacological manipulation using the mGlu5 negative allosteric modulator MTEP and the positive allosteric modulator CDPPB. Adult (PND 56) and adolescent (PND 28) male C57BL/6J mice binge-drank for 14 days under 3-bottle-choice procedures for 2 h/day; control animals drank water only. Approximately 24 h following the final alcohol presentation, animals were treated with 30 mg/kg IP MTEP, CDPPB, or vehicle and then tested, thirty minutes later, for behavioral signs of anxiety. Vehicle-treated binge-drinking adults exhibited hyperanxiety in all paradigms, while vehicle-treated binge-drinking adolescents did not exhibit withdrawal-induced anxiety. In adults, 30 mg/kg MTEP decreased alcohol-induced anxiety across paradigms, while 3 mg/kg MTEP was anxiolytic in adult water controls. CDPPB was modestly anxiogenic in both alcohol- and water-drinking mice. Adolescent animals showed minimal response to either CDPPB or MTEP, suggesting that anxiety in adolescence may be mGlu5-independent. These results demonstrate a causal role for mGlu5 in withdrawal-induced anxiety in adults and suggest age-related differences in the behavioral pharmacology of the negative reinforcing properties of alcohol.

Keywords: Adolescence; Alcoholism; Anxiety; Binge-drinking; Group 1 metabotropic glutamate receptors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Animals
  • Anxiety / chemically induced
  • Anxiety / drug therapy
  • Anxiety / metabolism*
  • Benzamides / pharmacology
  • Benzamides / therapeutic use
  • Binge Drinking / drug therapy
  • Binge Drinking / metabolism*
  • Dose-Response Relationship, Drug
  • Ethanol / administration & dosage
  • Ethanol / toxicity*
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Nucleus Accumbens / drug effects
  • Nucleus Accumbens / metabolism
  • Pyrazoles / pharmacology
  • Pyrazoles / therapeutic use
  • Pyridines / pharmacology
  • Pyridines / therapeutic use
  • Receptor, Metabotropic Glutamate 5 / antagonists & inhibitors
  • Receptor, Metabotropic Glutamate 5 / biosynthesis*
  • Substance Withdrawal Syndrome / drug therapy
  • Substance Withdrawal Syndrome / metabolism*
  • Thiazoles / pharmacology
  • Thiazoles / therapeutic use

Substances

  • 3-((2-methyl-1,3-thiazol-4-yl)ethynyl)pyridine
  • 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide
  • Benzamides
  • Pyrazoles
  • Pyridines
  • Receptor, Metabotropic Glutamate 5
  • Thiazoles
  • Ethanol